Abstract
The response of circulating somato-statin-like immunoactivity (SLI) to oral glucose and its relation to other pancreatic islet cell hormones were studied in 10 hypothyroid subjects before and after treatment. None of the patients suffered from diabetes mellitus or obesity. Compared with normal controls, the hypothyroid subjects had higher fasting and stimulated SLI levels but lower fasting pancreatic glucagon levels. Integrated glucose and insulin responses following glucose ingestion were normal, but the peak insulin réponse was delayed to 120 min suggesting impaired pancreatic β-cell response to oral glucose. On the other hand, the peak response of plasma C-peptide was higher probably because of a reduction in metabolic clearance. In both hypothyroid subjects and controls, a significant correlation was found between the maximal increment of SLI and the maximal decrement of glucagon following oral glucose. In conclusion, plasma SLI is increased in hypothyroidism. The changes in SLI may be due to either an increased hormonal secretion or a reduced metabolic clearance in hypothyroidism. This elevated SLI might contribute to the slower gastrointestinal motility observed in hypothyroidism. Our data also suggest that the reduction in glucagon secretion may be secondary to the increase in circulating SLI.
Similar content being viewed by others
References
Samols E., Bonner-Weir S., Weir G.C. Intra islet insulin-glucagon-somatostatin relationship. Clin. Endocrinol. Metab. 15: 33, 1986.
Berelowitz M., Maeda K., Harris S., Frohman L.A. The effect of alterations in the pituitary-thyroid axis on hypothalamic somatostatin content and in vitro release of somatostatin-like immunoreactivity. Endocrinology 107: 24, 1980.
Lamberg B.A. Glucose metabolism in thyroid disease. Acta. Med. Scand. 178: 351, 1965.
Andreani D., Menzinger G., Fallucca F., Aliberti G., Tamburrano G., Cassano C. Insulin levels in thyrotoxicosis and primary myxoedema: response of intravenous glucose and glucagon. Diabetologia 6: 1, 1970.
Skare S., Hanssen K.F., Norman N. Plasma somatostatin is elevated in primary hypothyroidism compared with hyperthyroidism. Acta Endocrinol. (Copenh.) 111: 331, 1986.
Ahren B., Lundquist I. Insulin secretory response to different secretogogues in hyper-and hypothyroid mice. Acta Endocrinol. (Copenh.) 97: 508, 1981.
Holdsworth C.D., Besser G.M. Influence of gastric emptying-rate and of insulin response on oral glucose tolerance in thyroid disease. Lancet 2: 700, 1986.
Beer S.F., Parr J.H.Y., Temple R.C., Hales C.N. The effect of thyroid disease on proinsulin and C-peptide levels. Clin. Endocrinol. (Oxf.) 30: 379, 1989.
Felt V. C. peptide during glucose loading in myxoedema. Horm. Metab. Res. 20: 375, 1988.
Lam S.K., Wong H., Ng M.M.T. Hypersomatostatinaemia in duodenal ulcer. J. Gastroenterol. Hepatol. 1: 119, 1986.
Heding L.G. Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7: 10, 1971.
Kuzuya H., Blix P.M., Horwitz D.L., Steinder D.F., Rubenstein A.H. Determination of free and total insulin and C-peptide in insulin-treated diabetes. Diabetes 26: 22, 1977.
Seltzer H.S., Allen E.W., Herron A.L., Brennan M.T. Insulin secretion in response to glycaemic stimulus: relation of delay initial release to carbohydrate intolerance in mild diabetes mellitus. J. Clin. Invest. 46: 323, 1967.
Shah J.H. Hypoinsulinemia of hypothyroidism. Arch. Intern. Med. 132: 657, 1973.
Polonsky K., Jaspan J., Pugh W., Cohen D., Schneider M., Schwartz T. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction J.Clin. Invest. 72: 1114, 1983.
Klaff L.J., Taborsky G.J. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycaemia. Diabetes 36: 592, 1987.
Duret R.L., Bastenie P.A. Intestinal disorders in hypothyroidism. Clinical and manometric study. Am. J. Dig. Dis. 16: 723, 1971.
Larsson L.I., Gotermann N., De Magistris L., Rehfeld J.F., Schwartz T.W. Somatostatin cell processes as pathways for paracrine secretion. Science 205: 1393, 1979.
Gerich J.E. Somatostatin. In: Brownlee M. (Ed.), Handbook of Diabetes Mellitus. Garland STPM Press, New York, London, 1981, vol. 1, p. 297.
Dubois A., Goldman J. Gastric secretion and emptying in hypothyroidism. Dig. Dis. Sci. 29: 407, 1984.
Taborsky G.T. Jr. Evidence of a paracrine role for pancreatic somatostatin in vivo. Am. J.Physiol. 245: 598, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kung, A.W.C., Lam, K.S.L., Pun, K.K. et al. Circulating somatostatin after oral glucose in hypothyroidism. J Endocrinol Invest 13, 403–406 (1990). https://doi.org/10.1007/BF03350690
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350690